SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-15-002398
Filing Date
2015-05-01
Accepted
2015-04-30 17:31:09
Documents
7
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_043015.htm 10-K/A 831890
2 EXHIBIT 10.42 exh_1042.htm EX-10.42 408528
3 EXHIBIT 31.1 exh_311.htm EX-31.1 17395
4 EXHIBIT 31.2 exh_312.htm EX-31.2 17749
5 EXHIBIT 32.1 exh_321.htm EX-32.1 7904
6 EXHIBIT 32.2 exh_322.htm EX-32.2 8133
7 graph.jpg GRAPHIC 39754
  Complete submission text file 0001171843-15-002398.txt   1347554
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34949 | Film No.: 15820596
SIC: 2834 Pharmaceutical Preparations